Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0334 per EA under NDC 00093342510. Its NADAC has been published 245 times since Dec 15, 2021.
FDA first approved this application on Oct 31, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093342510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072926FDA Approved
10/31/1991
TE Code
AB
On Market Since
10/11/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 245 times since Dec 15, 2021, and over the history we have for it it has declined 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0334 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0315 (Nov 20, 2024) |
| 52-week high | $0.0430 |
| 52-week low | $0.0328 |
| Median price | $0.0399 |
| Average price | $0.0396 |
| Largest weekly change | +28.1% (Aug 21, 2024) |
| Weeks tracked | 245 |
| Tracking since | Dec 15, 2021 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0334 per EA (NDC 00093342510), effective Aug 19, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 17.1%. It has been tracked across 245 weekly CMS publications since Dec 15, 2021.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Dec 15, 2021, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0315 (Nov 20, 2024) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0399 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 39% below LORAZEPAM 0.5 MG TABLET.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 00093342510) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.